为评估 TFPI 对慢性肾病（CKD）和糖尿病患者动脉粥样硬化血栓事件（ATE）的预测能力，研究发现 TFPI 在 CKD 患者中可预测 ATE，意义重大。 在心血管疾病（CVD）的防治领域，寻找精准预测心血管风险的生物标志物一直是研究热点。想象一下，我们若能提前知晓哪些 ...

The once-weekly anti-TFPI antibody has been cleared by the European Commission for adults and adolescents aged 123 and over with severe haemophilia A or B, without inhibitors, becoming the first ...

The results of the Explorer7 trial showed that concizumab – an anti-tissue factor pathway inhibitor (TFPI) antibody – reduced the number of treated bleeds in patients by 86% when given as a ...